Continuous caffeine consumption with smoking cessation has been associ
ated with more than doubled caffeine plasma levels. Such concentration
s may be sufficient to produce caffeine toxicity symptoms in smoking a
bstinence conditions. To test whether caffeine abstinence influences s
moking cessation, 162 caffeine-using smokers were enlisted from Americ
an Lung Association smoking cessation programs. Volunteers were random
ly assigned by clinic to caffeine-use and caffeine-abstinence conditio
ns and measured for 3 weeks post-smoking cessation, at 6 months and on
e year. Results showed a significant linear increase in caffeine sputu
m levels across 3 weeks post-cessation for those who quit smoking and
continued using caffeine. Three weeks after cessation, concentrations
reached 203% of baseline for the caffeine user. Typical nicotine withd
rawal symptoms occurred during the first 16 days of cessation. The caf
feine abstainers, but not continued users of caffeine, reported increa
sed fatigue during the first 3 days of cessation. Among complete caffe
ine abstainers, compared with caffeine users, there was a significant
increase in fatigue, a decrease in stimulation, and a marginal increas
e in caffeine craving immediately following tobacco cessation. There w
ere no differences between the groups on other withdrawal symptoms or
in cessation success at 16 days, 6 months, or 12 months. Copyright (C)
1996 Elsevier Science Ltd